One of us has run the lab. The other has built the systems.
You will talk to us directly. There is no channel partner between you and the people who write the software.
Gene has personally run CLIA/CAP-regulated laboratories processing toxicology and molecular PCR at volume, including high-volume tox work at Anchor Bioresearch. He came to diagnostics from big-pharma strategy at Amgen and Novartis, has founded a biotech, and leads life sciences business development. At Lab A SaaS he owns payer strategy, clearinghouse economics, and the billing model itself.
Daniel has built scalable high load products across regulated life-sciences environments — diagnostics, pharmacovigilance, clinical operations, and medical devices. He has led technical delivery for biotech clients including Roche Genentech, and Amgen through complex, mission-critical implementations. At Lab A SaaS he owns the multi-tenant architecture, the instrument interfaces, and the claim pipeline.
Talk to us directly.
No sales funnel, no SDR, no form that routes to a queue. You will reach one of the founders.